| 학회 |
한국공업화학회 |
| 학술대회 |
2020년 가을 (10/28 ~ 10/30, 광주 김대중컨벤션센터(Kimdaejung Convention Center)) |
| 권호 |
24권 1호 |
| 발표분야 |
[특별] COVID-19 및 팬데믹시대의 바이오테크널러지 |
| 제목 |
The COVID-19 pandemic and in-vitro diagnostic assays (코로나-19 대유행과 체외진단검사법) |
| 초록 |
Since the identification of novel coronavirus (SARS-CoV-2) infection in Wuhan, China in December 2019, it has become the greatest concern among public health issues. Timely and accurate diagnosis of Coronavirus disease 2019 (COVID-19) infection is important for appropriate treatment and limiting further spread of the virus. The current gold standard for diagnosing SARS-CoV-2 infection is a molecular test using real-time reverse transcription-polymerase chain reaction (rRT-PCR) with respiratory tract specimens. Serologic testing is emerging as an additional diagnostic tool for COVID-19. Although the current role of serologic tests remains confined to epidemiologic purposes, accurate assessment of immunologic response may provide several benefits. |
| 저자 |
이미경 |
| 소속 |
중앙대 |
| 키워드 |
COVID-19; PCR; Serologic testing
|
| E-Mail |
|
